Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

URGNUroGen Pharma Ltd.

Nasdaq · CIK 0001668243
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts303

Identity from submissions API

NameUroGen Pharma Ltd.
CIK0001668243
TickersURGN
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationL3 Israel
Phone972 9 770 7601
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
9 HA'TA'ASIYA ST
RA'ANANA
L3
4365007
Israel
Mailing address
9 HA'TA'ASIYA ST
RA'ANANA
L3
4365007
Israel

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

584 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000947263-26-000091 005-89992 261554166 34 10868
2026-11-04 S-8 FORM S-8 0001437749-26-034945 333-299817 261522366 33 234840 1 1
2026-11-04 10-Q FORM 10-Q 0001437749-26-034780 001-38079 261520349 34 8622720 1 1
2026-11-04 8-K FORM 8-K 2.02,9.01 0001437749-26-034769 001-38079 261520128 34 244550 1 1
2026-10-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003732 005-89992 261491564 34 10984
2026-10-09 4 FORM 4 0001437749-26-032421 8325
2026-10-09 144 xsl144X01/primary_doc.xml 0001976408-26-000887 001-38079 261451109 33 4420
2026-09-09 4 FORM 4 0001437749-26-029965 8307
2026-09-09 4 FORM 4 0001437749-26-029963 8308
2026-09-09 144 xsl144X01/primary_doc.xml 0001976408-26-000811 001-38079 261366683 33 4979
2026-09-09 144 xsl144X01/primary_doc.xml 0001976408-26-000810 001-38079 261366680 33 4383
2026-08-28 4 FORM 4 0001437749-26-029175 6510
2026-08-24 4 FORM 4 0001437749-26-028840 4866
2026-08-20 144 xsl144X01/primary_doc.xml 0001000275-26-000100 001-38079 261298726 33 5376
2026-08-20 8-K FORM 8-K 8.01 0001437749-26-028590 001-38079 261297246 34 151391 1 1
2026-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000947263-26-000072 005-89992 261267574 34 10864
2026-08-05 10-Q FORM 10-Q 0001437749-26-025794 001-38079 261241410 34 8875480 1 1
2026-08-05 8-K FORM 8-K 2.02,9.01 0001437749-26-025793 001-38079 261241406 34 267474 1 1
2026-07-10 4 FORM 4 0001437749-26-023290 5127
2026-07-09 144 xsl144X01/primary_doc.xml 0001000275-26-000093 001-38079 261165893 33 5562
2026-06-24 4 FORM 4 0001437749-26-021523 5043
2026-06-24 4 FORM 4 0001437749-26-021519 7577
2026-06-24 4 FORM 4 0001437749-26-021517 7630
2026-06-24 4 FORM 4 0001437749-26-021515 5182
2026-06-24 4 FORM 4 0001437749-26-021513 7613
2026-06-24 4 FORM 4 0001437749-26-021511 7593
2026-06-24 4 FORM 4 0001437749-26-021509 5208
2026-06-23 8-K FORM 8-K 3.03,5.02,5.07,9.01 0001437749-26-021442 001-38079 261111182 34 683750 1 1
2026-06-22 144 xsl144X01/primary_doc.xml 0001000275-26-000079 001-38079 261106862 33 4936
2026-06-09 4 FORM 4 0001437749-26-019964 8304
2026-06-09 144 xsl144X01/primary_doc.xml 0001976408-26-000558 001-38079 261074633 33 4982
2026-06-02 8-K FORM 8-K 8.01 0001437749-26-019102 001-38079 261053665 34 151340 1 1
2026-05-27 ARS FORM ARS 0001437749-26-018538 001-38079 261026029 34 9320262
2026-05-27 4 FORM 4 0001437749-26-018442 6513
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062615 005-89992 26988230 34 12419
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000947263-26-000047 005-89992 26985423 34 10664
2026-05-11 4 FORM 4 0001437749-26-016104 5039
2026-05-08 144 xsl144X01/primary_doc.xml 0001000275-26-000047 001-38079 26957241 33 4306
2026-05-06 10-Q FORM 10-Q 0001437749-26-015019 001-38079 26945892 34 9796491 1 1
2026-05-06 8-K FORM 8-K 2.02,9.01 0001437749-26-015018 001-38079 26945884 34 257978 1 1
2026-04-30 DEF 14A FORM DEF 14A 0001437749-26-014237 001-38079 26926242 34 3611265 1 1
2026-04-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-001661 005-89992 26901033 34 10817
2026-04-17 PRE 14A FORM PRE 14A 0001437749-26-012685 001-38079 26871611 34 3596620 1 1
2026-03-02 10-K FORM 10-K 0001437749-26-006234 001-38079 26703573 34 10654180 1 1
2026-03-02 8-K FORM 8-K 2.02,9.01 0001437749-26-006233 001-38079 26703561 34 267294 1 1
2026-03-02 8-K 8-K 1.01,2.03 0001193125-26-084282 001-38079 26703554 34 145972 1 1
2026-02-27 4 FORM 4 0001437749-26-006124 6375
2026-02-19 4 FORM 4 0001437749-26-004638 5179
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000947263-26-000006 005-89992 26630782 34 7045
2026-02-11 4 FORM 4 0001437749-26-003778 20313
2026-02-04 4 FORM 4 0001437749-26-003040 7211
2026-02-03 4 FORM 4 0001437749-26-002843 15948
2026-02-03 4 FORM 4 0001437749-26-002841 5183
2026-02-03 144 xsl144X01/primary_doc.xml 0001976408-26-000031 001-38079 26590178 33 5690
2025-12-01 4 FORM 4 0001437749-25-036576 6342
2025-12-01 4 FORM 4 0001437749-25-036565 6360
2025-12-01 4 FORM 4 0001437749-25-036559 6376
2025-12-01 4 FORM 4 0001437749-25-036557 6339
2025-12-01 4 FORM 4 0001437749-25-036555 6323
2025-11-20 4 FORM 4 0001437749-25-035821 4903
2025-11-19 144 xsl144X01/primary_doc.xml 0001000275-25-000163 001-38079 251498890 33 4930
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112620 005-89992 251487202 34 12264
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000947263-25-000010 005-89992 251482925 34 7049
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001771015-25-000010 005-89992 251482920 34 6861
2025-11-06 S-8 S-8 0001193125-25-269706 333-291325 251458880 33 196828 1 1
2025-11-06 S-3ASR S-3ASR 0001193125-25-269643 333-291323 251458706 33 1524364 1 1
2025-11-06 10-Q FORM 10-Q 0001437749-25-033468 001-38079 251456258 34 8821766 1 1
2025-11-06 8-K FORM 8-K 2.02,9.01 0001437749-25-033466 001-38079 251456237 34 269106 1 1
2025-10-09 4 FORM 4 0001437749-25-030772 8188
2025-09-09 4 FORM 4 0001437749-25-028707 8175
2025-09-09 4 FORM 4 0001437749-25-028705 8174
2025-09-09 144 xsl144X01/primary_doc.xml 0001976408-25-000296 001-38079 251301892 33 5254
2025-09-09 144 xsl144X01/primary_doc.xml 0001976408-25-000295 001-38079 251301689 33 4660
2025-08-27 4 FORM 4 0001437749-25-027883 7440
2025-08-27 4 FORM 4 0001437749-25-027882 7493
2025-08-27 4 FORM 4 0001437749-25-027880 7458
2025-08-27 4 FORM 4 0001437749-25-027879 7426
2025-08-27 4 FORM 4 0001437749-25-027878 7456
2025-08-27 4 FORM 4 0001437749-25-027877 5071
2025-08-27 8-K FORM 8-K 5.02,5.07,9.01 0001437749-25-027874 001-38079 251265763 34 449837 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-022035 005-89992 251221581 34 12591
2025-08-13 4 FORM 4 0001437749-25-026377 4695
2025-08-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-076875 005-89992 251207227 34 15910
2025-08-07 10-Q FORM 10-Q 0001437749-25-025243 001-38079 251191733 34 8537942 1 1
2025-08-07 8-K FORM 8-K 2.02,9.01 0001437749-25-025242 001-38079 251191712 34 259210 1 1
2025-08-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000471 005-89992 251189301 34 7735
2025-08-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-072156 005-89992 251185946 34 19677
2025-07-30 4 FORM 4 0001437749-25-023969 5337
2025-07-30 4 FORM 4 0001437749-25-023963 6126
2025-07-30 4 FORM 4 0001437749-25-023961 6129
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001085146-25-004272 005-89992 251162584 34 6554
2025-07-29 144 xsl144X01/primary_doc.xml 0001976408-25-000249 001-38079 251157558 33 4696
2025-07-29 144 xsl144X01/primary_doc.xml 0001976408-25-000248 001-38079 251157547 33 4113
2025-07-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002462 005-89992 251128416 34 10739
2025-07-16 ARS ANNUAL REPORT 0001437749-25-022781 001-38079 251126314 34 10303191
2025-07-15 DEF 14A FORM DEF 14A 0001437749-25-022732 001-38079 251125370 34 2679196 1 1
2025-07-03 8-K 8-K 5.02 0001193125-25-155503 001-38079 251105760 34 136013 1 1
2025-06-16 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-054819 005-89992 251050936 34 33194
2025-06-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001085146-25-003449 005-89992 251045238 34 6432
2025-06-13 8-K 8-K 8.01 0001193125-25-140339 001-38079 251044772 34 141194 1 1
2025-06-11 4 FORM 4 0001437749-25-020045 8170
2025-06-10 144 xsl144X01/primary_doc.xml 0001976408-25-000193 001-38079 251036072 33 4112
2025-06-09 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001999371-25-007493 005-89992 251035555 34 36435
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-013190 005-89992 25954933 34 18753
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002237 005-89992 25932849 34 12356
2025-05-12 10-Q FORM 10-Q 0001437749-25-015956 001-38079 25932693 34 8528765 1 1
2025-05-12 8-K FORM 8-K 2.02,9.01 0001437749-25-015955 001-38079 25932682 34 255920 1 1
2025-04-30 10-K/A FORM 10-K/A 0001437749-25-013839 001-38079 25894727 34 920187 1 1
2025-03-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001178913-25-000862 005-89992 25743535 34 8700
2025-03-10 10-K FORM 10-K 0001437749-25-006842 001-38079 25724249 34 10320747 1 1
2025-03-10 8-K FORM 8-K 2.02,9.01 0001437749-25-006757 001-38079 25722201 34 263145 1 1
2025-02-20 8-K 8-K 1.01,3.02 0001193125-25-030143 001-38079 25643341 34 148148 1 1
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000866 005-89992 25612620 34 12311
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000235 005-89992 25591262 34 8005
2025-02-04 4 FORM 4 0001437749-25-002688 20325
2025-02-04 4 FORM 4 0001437749-25-002685 20320
2025-02-04 4 FORM 4 0001437749-25-002683 5183
2025-01-14 8-K 8-K 7.01,9.01 0001193125-25-005649 001-38079 25527736 34 18068027 1 1
2024-11-18 SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 0001213900-24-099322 005-89992 241469702 34 90602
2024-11-14 SC 13G/A UROGEN PHARMA LTD. 0000902664-24-006639 005-89992 241465281 34 65485
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119305 005-89992 241464743 34 92228
2024-11-14 SC 13G/A greatpoint-urgn093024a2.htm 0001172661-24-005288 005-89992 241463680 34 110193
2024-11-14 SC 13G/A SC 13G/A 0001178913-24-003701 005-89992 241459163 34 99812
2024-11-14 SC 13G/A UROGEN PHARMA LTD. 0000902664-24-006499 005-89992 241457000 34 66076
2024-11-13 SC 13G/A COWEN AND COMPANY, LLC 0001085146-24-005686 005-89992 241457417 34 37358
2024-11-12 SC 13G UROGEN PHARMA LTD. 0000902664-24-006395 005-89992 241444178 34 80217
2024-11-08 SC 13G il0011407140_110824.txt 0002012383-24-003700 005-89992 241439848 34 13662
2024-11-06 SC 13G MS INITIAL 0000895421-24-000502 005-89992 241430170 34 12599
2024-11-06 10-Q FORM 10-Q 0001437749-24-033454 001-38079 241429304 34 7698598 1 1
2024-11-06 8-K 8-K 2.02,9.01 0001193125-24-251712 001-38079 241429295 34 238121 1 1
2024-10-24 SC 13G il0011407140_102424.txt 0002012383-24-002179 005-89992 241392090 34 13650
2024-10-09 4 xslF345X05/form4-10092024_081051.xml 0001415889-24-024932 7803
2024-10-09 3 xslF345X02/form3-10092024_081043.xml 0001415889-24-024930 8535
2024-10-09 8-K 8-K 5.02,9.01 0001193125-24-234808 001-38079 241361537 34 275056 1 1
2024-09-24 8-K 8-K 2.03 0001193125-24-224801 001-38079 241320387 34 148947 1 1
2024-09-13 8-K 8-K 5.02 0001193125-24-218868 001-38079 241297934 34 143706 1 1
2024-09-12 4 FORM 4 0001437749-24-029040 8182
2024-09-12 4 FORM 4 0001437749-24-029038 8181
2024-09-12 4 FORM 4 0001437749-24-029036 6630
2024-09-10 144 xsl144X01/primary_doc.xml 0001976408-24-000246 001-38079 241288744 33 4703
2024-08-15 8-K 8-K 8.01 0001193125-24-200993 001-38079 241210687 34 143038 1 1
2024-08-13 S-8 FORM S-8 0001437749-24-026414 333-281520 241202108 33 80329
2024-08-13 10-Q FORM 10-Q 0001437749-24-026161 001-38079 241198862 34 7285376 1 1
2024-08-13 8-K 8-K 2.02,9.01 0001193125-24-199425 001-38079 241198847 34 243147 1 1
2024-08-08 8-K 8-K 5.02,5.07,9.01 0001193125-24-197008 001-38079 241188971 34 407004 1 1
2024-08-08 4 FORM 4 0001437749-24-025299 5078
2024-08-08 4 FORM 4 0001437749-24-025298 5037
2024-08-08 4 FORM 4 0001437749-24-025297 5033
2024-08-08 4 FORM 4 0001437749-24-025295 5052
2024-08-08 4 FORM 4 0001437749-24-025293 5026
2024-08-08 4 FORM 4 0001437749-24-025292 5049
2024-08-08 4 FORM 4 0001437749-24-025291 5020
2024-07-09 ARS urgnars.pdf 0001437749-24-022420 001-38079 241108203 34 9115552
2024-07-01 DEFA14A FORM DEFA14A 0001437749-24-021723 001-38079 241090996 34 296028
2024-07-01 DEF 14A FORM DEF 14A 0001437749-24-021722 001-38079 241090978 34 1335917
2024-06-24 SC 13G COWEN AND COMPANY, LLC 0001085146-24-002732 005-89992 241065404 34 35964
2024-06-24 SC 13G UROGEN PHARMA LTD. 0000902664-24-004451 005-89992 241065036 34 75076
2024-06-18 8-K 8-K 1.01,8.01,9.01 0001193125-24-163498 001-38079 241052894 34 658109 1 1
2024-06-18 424B5 424B5 0001193125-24-163496 333-268398 241052863 33 683850
2024-06-17 424B5 424B5 0001193125-24-162621 333-268398 241048542 33 685135
2024-06-13 8-K 8-K 7.01,8.01,9.01 0001193125-24-160413 001-38079 241040336 34 21600422 1 1
2024-06-11 4 FORM 4 0001437749-24-019900 8178
2024-06-11 144 xsl144X01/primary_doc.xml 0001976408-24-000148 001-38079 241034572 33 4121
2024-05-13 10-Q FORM 10-Q 0001437749-24-016116 001-38079 24936961 34 6737362 1 1
2024-05-13 8-K 8-K 2.02,9.01 0001193125-24-136728 001-38079 24936949 34 228500 1 1
2024-05-08 SC 13G/A il0011407140_050724.txt 0001086364-24-007581 005-89992 24925321 34 12465
2024-04-29 10-K/A FORM 10-K/A 0001437749-24-013504 001-38079 24886709 34 774971 1 1
2024-03-20 4 FORM 4 0001437749-24-008707 4368
2024-03-18 144 xsl144X01/primary_doc.xml 0001000275-24-000026 001-38079 24758215 33 4122
2024-03-14 10-K FORM 10-K 0001437749-24-007753 001-38079 24748014 34 10864467 1 1
2024-03-14 8-K 8-K 2.02,9.01 0001193125-24-067432 001-38079 24748011 34 245862 1 1
2024-03-04 8-K 8-K 7.01,9.01 0001193125-24-056770 001-38079 24712816 34 22465207 1 1
2024-03-01 8-K 8-K 7.01 0001193125-24-054393 001-38079 24706866 34 150688 1 1
2024-02-22 SC 13D/A SC 13D/A 0001178913-24-000695 005-89992 24662563 34 47243
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024007 005-89992 24640143 34 99979
2024-02-14 SC 13G/A greatpoint-urgn123123a1.htm 0001172661-24-001527 005-89992 24639443 34 112695
2024-02-14 SC 13G/A SC 13G/A 0001178913-24-000537 005-89992 24633417 34 98887
2024-02-14 SC 13G UROGEN PHARMA LTD. 0000902664-24-001542 005-89992 24632224 34 66117
2024-02-13 SC 13G/A urgn13ga2024.htm 0000935836-24-000143 005-89992 24633412 34 58767
2024-02-12 4/A FORM 4/A 0001437749-24-003794 4701
2024-02-12 4/A FORM 4/A 0001437749-24-003792 5988
2024-02-07 8-K 8-K 7.01,9.01 0001193125-24-026699 001-38079 24604505 34 21298438 1 1
2024-02-05 4/A FORM 4/A 0001437749-24-003155 7559
2024-02-05 4/A FORM 4/A 0001437749-24-003153 7563
2024-02-02 4 FORM 4 0001437749-24-003018 20315
2024-02-02 4 FORM 4 0001437749-24-003016 20324
2024-02-02 4 FORM 4 0001437749-24-003014 8803
2024-02-02 4 FORM 4 0001437749-24-003012 5183
2024-02-02 SC 13G il0011407140_020224.txt 0001086364-24-006217 005-89992 24590257 34 13330
2024-02-01 144 xsl144X01/primary_doc.xml 0001976408-24-000032 001-38079 24585348 33 5164
2024-02-01 144 xsl144X01/primary_doc.xml 0001976408-24-000031 001-38079 24585294 33 5168
2024-01-17 8-K 8-K 1.01,8.01 0001193125-24-009259 001-38079 24538594 34 155426 1 1
2024-01-02 8-K 8-K 1.01 0001193125-24-000244 001-38079 24500297 34 146327 1 1
2023-12-29 SC 13G SC 13G 0001104659-23-130500 005-89992 231528089 34 86069
2023-12-05 UPLOAD filename1.pdf 0000000000-23-013213 39489
2023-11-27 CORRESP filename1.htm 0001193125-23-283042 14040
2023-11-16 UPLOAD filename1.pdf 0000000000-23-012561 43772
2023-11-14 S-8 S-8 0001193125-23-277126 333-275547 231406684 33 88573
2023-11-14 10-Q FORM 10-Q 0001437749-23-031766 001-38079 231401737 34 7379197 1 1
2023-11-14 8-K 8-K 2.02,9.01 0001193125-23-276676 001-38079 231401662 34 244180 1 1
2023-09-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-09-15 16:00:00 9999999995-23-002681 333-274423 231260024 33 1656
2023-09-15 SC 13G greatpoint-urgn090823.htm 0001172661-23-003255 005-89992 231257708 34 112576
2023-09-13 CORRESP filename1.htm 0001193125-23-233859 6952
2023-09-12 UPLOAD filename1.pdf 0000000000-23-010094 40170
2023-09-11 8-K 8-K 5.02,5.07 0001193125-23-232477 001-38079 231247933 34 166428 1 1
2023-09-08 S-3 S-3 0001193125-23-231552 333-274423 231245496 33 312395
2023-09-08 4 FORM 4 0001437749-23-025486 4873
2023-09-08 4 FORM 4 0001437749-23-025485 4815
2023-09-08 4 FORM 4 0001437749-23-025484 4832
2023-09-08 4 FORM 4 0001437749-23-025483 4828
2023-09-08 4 FORM 4 0001437749-23-025482 4847
2023-09-08 4 FORM 4 0001437749-23-025481 4821
2023-09-08 4 FORM 4 0001437749-23-025480 4844
2023-09-08 4 FORM 4 0001437749-23-025479 5087
2023-09-08 4 FORM 4 0001437749-23-025478 5088
2023-09-08 4 FORM 4 0001437749-23-025476 5085
2023-09-05 4 FORM 4 0001437749-23-025204 8119
2023-08-14 D xslFormDX01/primary_doc.xml 06b 0001668243-23-000001 021-489628 231168521 33 18185
2023-08-10 10-Q FORM 10-Q 0001437749-23-022879 001-38079 231157256 34 6836814 1 1
2023-08-10 8-K 8-K 2.02,9.01 0001193125-23-208139 001-38079 231157252 34 242036 1 1
2023-08-04 SC 13D SC 13D 0001140361-23-037975 005-89992 231142330 34 195379
2023-08-01 ARS urgnars.pdf 0001437749-23-021418 001-38079 231132125 34 4681546
2023-08-01 DEFA14A FORM DEFA14A 0001437749-23-021415 001-38079 231132052 34 260919
2023-08-01 DEF 14A FORM DEF 14A 0001437749-23-021412 001-38079 231132023 34 1723550
2023-07-28 4 FORM 4 0001437749-23-021073 4535
2023-07-28 4/A FORM 4/A 0001437749-23-021072 4882
2023-07-27 4 FORM 4 0001437749-23-020905 4803
2023-07-27 3 FORM 3 0001437749-23-020903 2598
2023-07-27 8-K 8-K 1.01,3.02,7.01,8.01,9.01 0001193125-23-195560 001-38079 231115617 34 33020733 1 1
2023-07-25 8-K 8-K 5.02 0001193125-23-193453 001-38079 231108767 34 143969 1 1
2023-06-12 SC 13G/A SC 13G/A 0001178913-23-002198 005-89992 231007192 34 112196
2023-06-09 4 FORM 4 0001437749-23-017046 5120
2023-05-11 8-K 8-K 2.02,9.01 0001193125-23-141462 001-38079 23908941 34 226364 1 1
2023-05-11 10-Q FORM 10-Q 0001437749-23-013767 001-38079 23908930 34 6233967 1 1
2023-05-01 10-K/A 10-K/A 0001193125-23-130561 001-38079 23874350 34 693708 1 1
2023-03-24 10-K FORM 10-K 0001437749-23-007710 001-38079 23757723 34 8779433 1 1
2023-03-22 8-K 8-K 2.02,9.01 0001193125-23-076682 001-38079 23752973 34 262960 1 1
2023-02-28 4/A FORM 4/A 0001437749-23-004870 6972
2023-02-28 4/A FORM 4/A 0001437749-23-004868 8950
2023-02-28 4 FORM 4 0001437749-23-004866 6393
2023-02-13 SC 13G/A urgn13ga.htm 0000935836-23-000137 005-89992 23615632 34 59277
2023-02-02 4 FORM 4 0001437749-23-002358 17184
2023-02-02 4 FORM 4 0001437749-23-002340 7243
2023-02-02 4 FORM 4 0001437749-23-002338 17400
2023-02-02 4 FORM 4 0001437749-23-002336 22474
2023-01-23 4 FORM 4 0001437749-23-001625 6127
2022-12-01 SC 13G urogen.htm 0000935836-22-000637 005-89992 221440887 34 59734
2022-12-01 424B5 424B5 0001193125-22-296511 333-268398 221438868 33 218752
2022-11-29 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-11-29 16:00:00 9999999995-22-003411 333-268398 221434180 33 1656
2022-11-23 CORRESP filename1.htm 0001193125-22-291878 7642
2022-11-22 UPLOAD filename1.pdf 0000000000-22-012636 40148
2022-11-16 S-3/A FORM S-3/A 0001437749-22-027542 333-268398 221395651 33 96945
2022-11-15 S-3 FORM S-3 0001437749-22-027467 333-268398 221391798 33 1576339
2022-11-10 8-K 8-K 2.02,9.01 0001193125-22-281988 001-38079 221375057 34 237688 1 1
2022-11-10 10-Q FORM 10-Q 0001437749-22-026727 001-38079 221375041 34 6835129 1 1
2022-11-09 3 DW 11082022 FORM 3 0001437749-22-026636 2617
2022-11-09 4 DW 11082022 0001437749-22-026635 4785
2022-11-09 8-K 8-K 5.02 0001193125-22-280620 001-38079 221370549 34 143394 1 1
2022-11-02 4 MS 11022022 0001437749-22-025549 8148
2022-10-25 4 RN 10252022 0001437749-22-024711 8566
2022-10-21 8-K 8-K 2.03 0001193125-22-266722 001-38079 221323850 34 149655 1 1
2022-09-16 4 FORM 4 0001437749-22-022616 6077
2022-09-12 3 FORM 3 0001437749-22-022163 2621
2022-09-12 4 FORM 4 0001437749-22-022162 4795
2022-09-12 8-K FORM 8-K 5.02 0001437749-22-022160 001-38079 221237439 34 158890 1 1
2022-09-02 4 FORM 4 0001437749-22-021777 6076
2022-09-02 4 FORM 4 0001437749-22-021776 8092
2022-08-25 4 FORM 4 0001437749-22-021338 6389
2022-08-25 4 FORM 4 0001437749-22-021337 8143
2022-08-11 10-Q FORM 10-Q 0001437749-22-020131 001-38079 221156053 34 6627480 1 1
2022-08-11 S-8 S-8 0001193125-22-218027 333-266761 221153793 33 80818
2022-08-11 8-K 8-K 2.02,9.01 0001193125-22-218026 001-38079 221153786 34 237846 1 1
2022-07-08 SC 13G il0011407140_070822.txt 0000834237-22-010336 005-89992 221075101 34 12227
2022-06-13 8-K FORM 8-K 5.02,5.07,9.01 0001437749-22-014892 001-38079 221012302 34 363469 1 1
2022-06-10 4 AB 06102022 0001437749-22-014774 4845
2022-06-10 4 CB 06102022 0001437749-22-014773 4787
2022-06-10 4 FC 06102022 0001437749-22-014772 4804
2022-06-10 4 SH 06102022 0001437749-22-014771 4819
2022-06-10 4 RN 06102022 0001437749-22-014770 7127
2022-05-17 DEFA14A DEFA14A 0001193125-22-152998 001-38079 22934476 34 52349
2022-05-10 8-K 8-K 2.02,9.01 0001193125-22-145810 001-38079 22907611 34 229864 1 1
2022-05-10 10-Q FORM 10-Q 0001437749-22-011618 001-38079 22907591 34 7578586 1 1
2022-05-03 4 MS 05032022 FORM 4 0001437749-22-010701 8154
2022-05-02 DEFA14A FORM DEFA14A 0001437749-22-010484 001-38079 22882880 34 371450
2022-05-02 DEF 14A FORM DEF 14A 0001437749-22-010483 001-38079 22882866 34 1813276
2022-03-29 4 FORM 4 SUBMISSION 0001209191-22-021524 5305
2022-03-29 3 FORM 3 SUBMISSION 0001209191-22-021521 8218
2022-03-21 S-8 S-8 0001193125-22-080104 333-263729 22754296 33 79879
2022-03-21 8-K 8-K 2.02,5.02,9.01 0001193125-22-080081 001-38079 22754260 34 321181 1 1
2022-03-21 10-K FORM 10-K 0001437749-22-006778 001-38079 22754237 34 8576525 1 1
2022-03-08 8-K 8-K 1.01,2.03 0001193125-22-068800 001-38079 22720522 34 155117 1 1
2022-02-14 SC 13G/A AMENDED ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-22-001901 005-89992 22632167 34 82709
2022-02-14 SC 13G/A NONE 0001567619-22-004106 005-89992 22629006 34 69387
2022-02-04 SC 13G/A SEC SCHEDULE 13G 0001678858-22-000077 005-89992 22591241 34 32812
2022-02-03 SC 13G/A il0011407140_020322.txt 0000834237-22-006257 005-89992 22589012 34 13299
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006387 13426
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006385 13394
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006384 18972
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006383 16651
2022-01-28 4 FORM 4 SUBMISSION 0001209191-22-005416 8837
2022-01-07 4 FORM 4 SUBMISSION 0001209191-22-002305 8886
2021-12-02 4 FORM 4 SUBMISSION 0001209191-21-067440 8720
2021-12-02 4 FORM 4 SUBMISSION 0001209191-21-067439 8677
2021-11-19 4 FORM 4 SUBMISSION 0001209191-21-065756 4463
2021-11-15 8-K 8-K 1.02,2.02,9.01 0001193125-21-329000 001-38079 211406503 34 240550 1 1
2021-11-15 10-Q FORM 10-Q 0001437749-21-026620 001-38079 211406409 34 5834467 1 1
2021-11-10 8-K 8-K 8.01 0001193125-21-326173 001-38079 211397715 34 147985 1 1
2021-11-02 4 FORM 4 SUBMISSION 0001209191-21-062360 8842
2021-10-28 4 FORM 4 SUBMISSION 0001209191-21-061868 8841
2021-09-13 8-K 8-K 8.01 0001193125-21-270939 001-38079 211248684 34 153620 1 1
2021-08-05 S-8 S-8 0001193125-21-237825 333-258496 211149057 33 131166
2021-08-04 8-K 8-K 2.02,9.01 0001193125-21-235753 001-38079 211142421 34 239057 1 1
2021-08-04 10-Q 10-Q 0001564590-21-040510 001-38079 211142418 34 8137355 1 1
2021-08-03 4 FORM 4 SUBMISSION 0001209191-21-049477 8842
2021-07-28 4 FORM 4 SUBMISSION 0001209191-21-048398 8841
2021-07-14 8-K 8-K 2.02,8.01,9.01 0001193125-21-214667 001-38079 211089300 34 203184 1 1
2021-07-12 4/A FORM 4/A SUBMISSION 0001209191-21-046344 30187
2021-07-12 4/A FORM 4/A SUBMISSION 0001209191-21-046340 18871
2021-06-09 4/A FORM 4/A SUBMISSION 0001209191-21-039138 6979
2021-06-09 4/A FORM 4/A SUBMISSION 0001209191-21-039137 7288
2021-06-09 4 FORM 4 SUBMISSION 0001209191-21-039136 5193
2021-06-09 4 FORM 4 SUBMISSION 0001209191-21-039135 5176
2021-06-09 4 FORM 4 SUBMISSION 0001209191-21-039134 5229
2021-06-09 4 FORM 4 SUBMISSION 0001209191-21-039133 5313
2021-06-09 4 FORM 4 SUBMISSION 0001209191-21-039132 11763
2021-06-09 4 FORM 4 SUBMISSION 0001209191-21-039131 5234
2021-06-09 4 FORM 4 SUBMISSION 0001209191-21-039130 5208
2021-06-08 8-K 8-K 5.02,5.07,9.01 0001564590-21-032093 001-38079 211001948 34 513752 1 1
2021-06-08 4 FORM 4 SUBMISSION 0001209191-21-038842 5258
2021-06-08 4 FORM 4 SUBMISSION 0001209191-21-038841 5225
2021-05-21 4 FORM 4 SUBMISSION 0001209191-21-034823 14368
2021-05-18 4 FORM 4 SUBMISSION 0001209191-21-033402 4450
2021-05-18 4 FORM 4 SUBMISSION 0001209191-21-033399 4973
2021-05-13 8-K 8-K 2.02,9.01 0001193125-21-159839 001-38079 21917233 34 223915 1 1
2021-05-13 10-Q 10-Q 0001564590-21-027210 001-38079 21917201 34 7400872 1 1
2021-05-04 4 FORM 4 SUBMISSION 0001209191-21-029758 8843
2021-04-28 DEFA14A DEFA14A 0001564590-21-021333 001-38079 21864183 34 440726
2021-04-28 DEF 14A DEF 14A 0001564590-21-021330 001-38079 21864168 34 2735308
2021-04-27 4 FORM 4 SUBMISSION 0001209191-21-028500 8841
2021-04-22 4 FORM 4 SUBMISSION 0001209191-21-027978 6662
2021-04-22 4 FORM 4 SUBMISSION 0001209191-21-027977 6971
2021-03-18 8-K 8-K 2.02,9.01 0001193125-21-085031 001-38079 21753152 34 246966 1 1
2021-03-18 8-K 8-K 1.01,7.01,9.01 0001193125-21-085025 001-38079 21753151 34 176423 1 1
2021-03-18 10-K 10-K 0001564590-21-014016 001-38079 21753149 34 11805081 1 1
2021-02-12 SC 13G/A AMENDED ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-21-002247 005-89992 21627355 34 143703
2021-02-12 SC 13G NONE 0001567619-21-003470 005-89992 21627093 34 69429
2021-02-11 SC 13G/A SC 13G/A 0001178913-21-000436 005-89992 21616702 34 68423
2021-02-03 SC 13G/A SEC SCHEDULE 13G 0000902219-21-000042 005-89992 21585369 34 37346
2021-02-02 4 FORM 4 SUBMISSION 0001209191-21-006710 7741
2021-02-02 4 FORM 4 SUBMISSION 0001209191-21-006709 7756
2021-02-02 4 FORM 4 SUBMISSION 0001209191-21-006700 7783
2021-02-02 4 FORM 4 SUBMISSION 0001209191-21-006699 13519
2021-02-01 SC 13G/A il0011407140_013121.txt 0000834237-21-005462 005-89992 21574471 34 13212
2021-01-26 4 FORM 4 SUBMISSION 0001209191-21-005460 8842
2021-01-13 8-K 8-K 8.01,9.01 0001193125-21-007767 001-38079 21525095 34 147517 1 1
2021-01-11 8-K 8-K 7.01,9.01 0001193125-21-005843 001-38079 21519402 34 14625181 1 1
2020-12-15 4 FORM 4 SUBMISSION 0001209191-20-063558 4480
2020-12-07 4 FORM 4 SUBMISSION 0001209191-20-061921 8846
2020-12-04 4 FORM 4 SUBMISSION 0001209191-20-061812 7410
2020-12-03 8-K 8-K 8.01,9.01 0001193125-20-309507 001-38079 201366969 34 150994 1 1
2020-11-17 8-K 8-K 8.01,9.01 0001193125-20-296012 001-38079 201321315 34 153689 1 1
2020-11-09 8-K 8-K 2.02,9.01 0001564590-20-052224 001-38079 201296205 34 435725 1 1
2020-11-09 10-Q 10-Q 0001564590-20-052197 001-38079 201296120 34 7791563 1 1
2020-10-28 4 FORM 4 SUBMISSION 0001209191-20-056066 8847
2020-10-16 4 FORM 4 SUBMISSION 0001209191-20-055037 17454
2020-10-05 4 FORM 4 SUBMISSION 0001209191-20-053641 7734
2020-10-05 3 FORM 3 SUBMISSION 0001209191-20-053637 6283
2020-10-05 4/A FORM 4/A SUBMISSION 0001209191-20-053632 8168
2020-09-10 4 FORM 4 SUBMISSION 0001209191-20-049937 11451
2020-09-10 3 FORM 3 SUBMISSION 0001209191-20-049936 6308
2020-09-09 8-K 8-K 5.02,9.01 0001193125-20-241611 001-38079 201165481 34 274386 1 1
2020-09-08 4 FORM 4 SUBMISSION 0001209191-20-049741 8855
2020-09-01 4 FORM 4 SUBMISSION 0001209191-20-048883 8869
2020-08-27 8-K 8-K 8.01,9.01 0001193125-20-232097 001-38079 201139071 34 193968 1 1
2020-08-10 S-8 S-8 0001193125-20-215023 333-243750 201090240 33 48883
2020-08-10 10-Q 10-Q 0001564590-20-038611 001-38079 201087125 34 7592966 1 1
2020-08-10 8-K 8-K 2.02,9.01 0001564590-20-038598 001-38079 201087067 34 441294 1 1
2020-07-28 4 FORM 4 SUBMISSION 0001209191-20-043874 8867
2020-07-28 4 FORM 4 SUBMISSION 0001209191-20-043873 8850
2020-06-10 4 FORM 4 SUBMISSION 0001209191-20-035684 5322
2020-06-10 4 FORM 4 SUBMISSION 0001209191-20-035682 5216
2020-06-10 4 FORM 4 SUBMISSION 0001209191-20-035680 5217
2020-06-10 4 FORM 4 SUBMISSION 0001209191-20-035679 5238
2020-06-10 4 FORM 4 SUBMISSION 0001209191-20-035678 5202
2020-06-10 4 FORM 4 SUBMISSION 0001209191-20-035677 5185
2020-06-10 4 FORM 4 SUBMISSION 0001209191-20-035676 5243
2020-06-10 8-K 8-K 4.01,5.02,5.07,9.01 0001193125-20-165697 001-38079 20954860 34 381906 1 1
2020-06-05 4 FORM 4 SUBMISSION 0001209191-20-034672 8857
2020-05-20 4 FORM 4 SUBMISSION 0001209191-20-030900 8870
2020-05-15 8-K 8-K 8.01,9.01 0001193125-20-143480 001-38079 20881084 34 158396 1 1
2020-05-14 4 FORM 4 SUBMISSION 0001209191-20-029079 7416
2020-05-07 10-Q 10-Q 0001564590-20-022352 001-38079 20854520 34 6752564 1 1
2020-04-29 DEFA14A DEFA14A 0001564590-20-019415 001-38079 20827272 34 268726
2020-04-29 DEF 14A DEF 14A 0001564590-20-019410 001-38079 20827238 34 1388905
2020-04-28 4 FORM 4 SUBMISSION 0001209191-20-025904 8850
2020-04-28 4 FORM 4 SUBMISSION 0001209191-20-025903 8867
2020-04-28 4 FORM 4 SUBMISSION 0001209191-20-025893 8842
2020-04-16 8-K 8-K 8.01,9.01 0001193125-20-108412 001-38079 20794946 34 164789 1 1
2020-03-23 8-K 8-K 5.02,9.01 0001193125-20-081537 001-38079 20733561 34 204772 1 1
2020-03-04 4 FORM 4 SUBMISSION 0001209191-20-016275 9386

Latest XBRL company facts

One latest value per concept from companyfacts (303 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 49.05M 2026-10-28 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
dei EntityPublicFloat Entity Public Float USD 620.40M 2025-06-30 2025 FY 10-K 2026-03-02 0001437749-26-006234
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.08M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001437749-26-014237
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.18M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001437749-26-014237
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 11.84M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001437749-26-014237
ecd PeoTotalCompAmt PeoTotalCompAmt USD 4.31M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001437749-26-014237
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 264.04 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001437749-26-014237
ffd NetFeeAmt NetFeeAmt USD 4,596.38 2026-11-04 S-8 2026-11-04 0001437749-26-034945
ffd TtlFeeAmt TtlFeeAmt USD 4,596.38 2026-11-04 S-8 2026-11-04 0001437749-26-034945
ffd TtlOfferingAmt TtlOfferingAmt USD 52.83M 2026-11-04 S-8 2026-11-04 0001437749-26-034945
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-04 S-8 2026-11-04 0001437749-26-034945
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-04 S-8 2026-11-04 0001437749-26-034945
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 46.85M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 17.26M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 117.28M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 319,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap AccruedBonusesCurrentAndNoncurrent Accrued Bonuses USD 400,000 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022352
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 6.60M 2020-03-31 2021 FY 10-K 2022-03-21 0001437749-22-006778
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 4.82M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 399.60M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042553
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 873.75M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 16.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 18.64M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 16.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 1.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap Assets Assets USD 271.87M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap AssetsCurrent Assets, Current USD 251.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 1,000 2026-06-30 2026 Q2 10-Q 2026-08-05 0001437749-26-025794
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 3,000 2026-06-30 2026 Q2 10-Q 2026-08-05 0001437749-26-025794
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 28.84M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001437749-26-025794
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 6.35M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 28.84M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001437749-26-025794
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 4.99M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-21 0001437749-22-006778
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 51,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014016
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 85.56M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 52.40M 2022-06-30 2022 Q2 10-Q 2022-08-11 0001437749-22-020131
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 72.48M 2018-01-01 2018-09-30 2018 Q3 6-K 2018-11-13 0001564590-18-029081
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 90.50M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 86.89M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -25.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 52.40M 2022-06-30 2022 Q2 10-Q 2022-08-11 0001437749-22-020131
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 5.23M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share ILS/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 49.03M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 49.03M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap CommonStockValue Common Stock, Value, Issued USD 135,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -39.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice Contract with Customer, Asset, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price USD 135,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0001437749-25-006842
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 2.2 2017-04-19 2018 Q3 6-K 2018-11-13 0001564590-18-029081
us-gaap CostOfRevenue Cost of Revenue USD 18.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 196,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 78,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD -118,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 70.80M 2022-03-31 2022 Q1 10-Q 2022-05-10 0001437749-22-011618
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 75.00M 2022-03-31 2022 Q1 10-Q 2022-05-10 0001437749-22-011618
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss USD 100,000 2022-03-31 2022 Q1 10-Q 2022-05-10 0001437749-22-011618
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Security 0 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 26,000 2021-12-31 2021 FY 10-K 2022-03-21 0001437749-22-006778
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions pure 1 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.95M 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 650,000 2017-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005323
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 200.40M 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 527,000 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.95M 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 153.35M 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 2.60M 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 600,000 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.36M 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 20.03M 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 13.25M 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 2.97M 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 61,000 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 198.45M 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 1.90M 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 56,000 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap Depreciation Depreciation USD 207,000 2017-01-01 2017-12-31 2017 FY 20-F 2018-03-15 0001564590-18-005876
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 401,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-04 0001564590-21-040510
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 234,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap DividendsCommonStock Dividends, Common Stock USD 0 2004-04-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001437749-23-031766
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.78 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -4.96 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-21 0001437749-22-006778
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.24 2017-01-01 2017-12-31 2017 FY 20-F 2018-03-15 0001564590-18-005876
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.23 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.151 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 16.88M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 37.10M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 13.50M 2020-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014016
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 168,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2021-06-30 2021 Q2 10-Q 2021-08-04 0001564590-21-040510
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2021-06-30 2021 Q2 10-Q 2021-08-04 0001564590-21-040510
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2021-06-30 2021 Q2 10-Q 2021-08-04 0001564590-21-040510
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2021-06-30 2021 Q2 10-Q 2021-08-04 0001564590-21-040510
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-04 0001564590-21-040510
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-04 0001564590-21-040510
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-04 0001564590-21-040510
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-04 0001564590-21-040510
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD 168,000 2017-01-01 2017-09-30 2018 Q3 6-K 2018-11-13 0001564590-18-029081
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2017-09-30 2018 Q3 6-K 2018-11-13 0001564590-18-029081
us-gaap FinanceLeaseImpairmentLoss Finance Lease, Impairment Loss USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0001437749-25-006842
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 465,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 4.04M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 1.45M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 2.58M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 4.89M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 1.94M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 396,000 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 509,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 486,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 852,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 1.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 4.67M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 1.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.137 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -1,000 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042553
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD -100,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 60.20M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap GrossProfit Gross Profit USD 194.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-03-15 0001564590-18-005876
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -37.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 35.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -125.11M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014016
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 3.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 1.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 23.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 605,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -35.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 6.93M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0001437749-25-006842
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.05M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-24 0001437749-23-007710
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 89,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 175,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 597,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0001437749-25-006842
us-gaap IncomeTaxReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount USD 789,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 19.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 84.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD 657,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014016
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -650,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD 3.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 8.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -303,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 2.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 4,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042553
us-gaap InterestAndOtherIncome Interest and Other Income USD 1.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap InterestExpenseLongTermDebt Interest Expense, Long-term Debt USD 13.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 3.61M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042553
us-gaap InterestReceivable Interest Receivable USD 200,000 2021-06-30 2021 Q2 10-Q 2021-08-04 0001564590-21-040510
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 1.56M 2021-06-30 2021 Q2 10-Q 2021-08-04 0001564590-21-040510
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 16.85M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap InventoryNet Inventory, Net USD 25.15M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 2.89M 2021-06-30 2021 Q2 10-Q 2021-08-04 0001564590-21-040510
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 10.99M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap InventoryWriteDown Inventory Write-down USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001437749-24-007753
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 2.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap Investments Investments USD 6.35M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 1.20M 2018-01-01 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042553
us-gaap LeaseCost Lease, Cost USD 2.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 3.59M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 999,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 301,000 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042553
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 613,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 613,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 913,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 248,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 702,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LessorOperatingLeasePaymentsToBeReceived Lessor, Operating Lease, Payments to be Received USD 49,000 2023-12-31 2023 FY 10-K 2024-03-14 0001437749-24-007753
us-gaap LessorOperatingLeasePaymentsToBeReceivedFourYears Lessor, Operating Lease, Payment to be Received, Year Four USD 49,000 2020-12-31 2021 FY 10-K 2022-03-21 0001437749-22-006778
us-gaap LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths Lessor, Operating Lease, Payment to be Received, Year One USD 49,000 2023-12-31 2023 FY 10-K 2024-03-14 0001437749-24-007753
us-gaap LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year USD 63,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0001437749-23-031766
us-gaap LessorOperatingLeasePaymentsToBeReceivedThreeYears Lessor, Operating Lease, Payment to be Received, Year Three USD 49,000 2021-12-31 2022 FY 10-K 2023-03-24 0001437749-23-007710
us-gaap LessorOperatingLeasePaymentsToBeReceivedTwoYears Lessor, Operating Lease, Payment to be Received, Year Two USD 49,000 2022-12-31 2023 FY 10-K 2024-03-14 0001437749-24-007753
us-gaap Liabilities Liabilities USD 397.09M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 271.87M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LiabilitiesCurrent Liabilities, Current USD 74.03M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 1.75M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042553
us-gaap LiabilityForUncertainTaxPositionsNoncurrent Liability for Uncertainty in Income Taxes, Noncurrent USD 3.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LongTermDebt Long-term Debt USD 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 0 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 50.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 150.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 189.35M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD -100,000 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042553
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 67.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 839,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -93.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -39.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -128.48M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014016
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 4.10M 2015-01-01 2015-12-31 2017 FY 20-F 2018-03-15 0001564590-18-005876
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -744,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap OperatingExpenses Operating Expenses USD 109.50M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -11.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap OperatingLeaseCost Operating Lease, Cost USD 717,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.20M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-06 0001437749-26-015019
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.89M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 707,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 2.18M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap OperatingLeasePayments Operating Lease, Payments USD 590,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.69M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 4.53M 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014016
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.76M 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014016
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 301,000 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 348,000 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014016
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.10M 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014016
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.27M 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014016
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.118 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 626.70M 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 3.34M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 11.86M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -226,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-04 0001564590-21-040510
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 8.14M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -284,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 214,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-06 0001437749-26-015019
us-gaap OtherSellingGeneralAndAdministrativeExpense Other Selling, General and Administrative Expense USD 1.33M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-06 0001437749-26-015019
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-04 0001564590-21-040510
us-gaap PaymentsForProceedsFromShortTermInvestments Payments for (Proceeds from) Short-term Investments USD -35.90M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 215,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001437749-24-007753
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 24.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 4.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 186,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap PaymentsToAcquireRestrictedInvestments Payments to Acquire Restricted Investments USD 172,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014016
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 36.00M 2017-01-01 2017-12-31 2017 FY 20-F 2018-03-15 0001564590-18-005876
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.08 2017-01-01 2017-12-31 2017 FY 20-F 2018-03-15 0001564590-18-005876
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 825,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 17.58M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 65.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 21.58M 2015-01-01 2015-12-31 2017 FY 20-F 2018-03-15 0001564590-18-005876
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 120.00M 2023-07-26 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 29.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 26.30M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-04 0001564590-21-040510
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-24 0001437749-23-007710
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 35.90M 2018-01-01 2018-09-30 2018 Q3 6-K 2018-11-13 0001564590-18-029081
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 3.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 382,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 5.41M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 588,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 58.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 9.71M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-06 0001437749-26-015019
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 4.10M 2015-01-01 2015-12-31 2017 FY 20-F 2018-03-15 0001564590-18-005876
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 1.33M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap RestrictedInvestmentsCurrent Restricted Investments, Current USD 523,000 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042553
us-gaap RestrictedInvestmentsNoncurrent Restricted Investments, Noncurrent USD 178,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -999.10M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 212.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap Revenues Revenues USD 1.13M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005323
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 456,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 2.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 147.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 16.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 2.87M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 2.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 496,417 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-24 0001437749-23-007710
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 122,500 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 1.60M 2023-12-31 2023 FY 10-K 2024-03-14 0001437749-24-007753
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 9,600 2016-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007970
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 27.97 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-24 0001437749-23-007710
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 11.52 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 1.83M 2023-12-31 2023 FY 10-K 2024-03-14 0001437749-24-007753
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 2.69M 2023-12-31 2023 FY 10-K 2024-03-14 0001437749-24-007753
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit USD/shares 19.5 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap SharesPaidForTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation shares 68,416 2017-01-01 2017-12-31 2017 FY 20-F 2018-03-15 0001564590-18-005876
us-gaap ShortTermInvestments Short-term Investments USD 6.35M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit USD 1.40M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001437749-25-033468
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -125.22M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 3.2 2017-04-19 2018 Q3 6-K 2018-11-13 0001564590-18-029081
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 3,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 11.10M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 3.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap SubleaseIncome Sublease Income USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 100,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005323
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 1.81M 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 717,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 2.10M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0001437749-25-006842
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 550,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 29.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001437749-26-006234
us-gaap VariableLeaseCost Variable Lease, Cost USD 487,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 22.35M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-21 0001437749-22-006778
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 50.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001437749-26-034780

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →